PIP-199 |
Katalog-Nr.GC61188 |
PIP-199 ist ein selektiver Inhibitor der RMI (RecQ-mediated genome instability protein)-Kernkomplex/MM2-Interaktion mit einem IC50 von 36 μM. PIP-199 kann fÜr die Erforschung der Sensibilisierung resistenter Tumore gegenÜber DNA-vernetzenden Chemotherapeutika verwendet werden.
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 622795-76-0
Sample solution is provided at 25 µL, 10mM.
PIP-199 is a selective inhibitor of RMI (RecQ-mediated genome instability protein) core complex/MM2 interaction, with an IC50 of 36 μM. MM2 is the binding site of RMI complex on Fanconi anemia complementation group M protein (FANCM). PIP-199 can be used for the research of sensitizing resistant tumors to DNA crosslinking chemotherapeutics[1].
Induction of the Fanconi anemia (FA) DNA repair pathway is a common mechanism by which tumors evolve resistance to DNA crosslinking chemotherapies[1].Proper execution of the FA pathway requires interaction between the FANCM and the RMI complex, and mutations that disrupt FANCM/RMI interactions sensitize cells to DNA crosslinking agents[1].
[1]. Andrew F. Voter, et al. A high throughput screening strategy to identify protein-protein interaction inhibitors that block the Fanconi anemia DNA repair pathway. J Biomol Screen. 2016 Jul; 21(6): 626-633.
Average Rating: 5
(Based on Reviews and 34 reference(s) in Google Scholar.)GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *